A Clinical Trial to Assess the Efficacy and Safety of the Combination of a Drug Call Quizartinib With Chemotherapy (FLAG-IDA) in Patients With Acute Myeloid Leukemia That Has Not Responded to the First Treatment or That Has Returned After the First Treatment
Clinical trial NCT04112589 · UNKNOWN
Trial details
- NCT number
- NCT04112589
- Sponsor
- PETHEMA Foundation
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-26
- Primary completion
- 2023-12-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.